InsidersTradesSigma
Track the 바이오인프라생명과학 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 바이오인프라생명과학 has recorded 12 public disclosures. The latest transaction was disclosed on 16 December 2024 (Purchase). Among the most active insiders: 이정호. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
12 of 12 declarations
BioInfra Life Science es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras para necesidades médicas.